Key result
Restrictive mitral annuloplasty for functional mitral regurgitation resulted in sustained improvement of hemodynamics and left ventricular function, while preoperative severe pulmonary hypertension strongly predicted postoperative adverse cardiac events (HR 6.8).
Population
44 patients with refractory heart failure and functional mitral regurgitation, mean age 62±9 years, 75%…
Design
Cohort, Echocardiography examiner was blinded to the clinical status of the…
Follow-up
mean 48±33 months
Authors
Loading...
Supports further evaluation of restrictive mitral annuloplasty in functional MR; leaves open randomized confirmation of durability and pulmonary hypertension risk stratification.
Cohort (n=44)
No
Hazard Ratio: 6.8 (95% CI 1.1–41.9)
p-value: p=0.04
Restrictive mitral annuloplasty in patients with advanced cardiomyopathy and functional mitral regurgitation provides sustained improvements in hemodynamics and left ventricular function, though preoperative severe pulmonary hypertension predicts worse outcomes.
Kainuma et al. (2010) conducted a cohort in Functional mitral regurgitation and advanced cardiomyopathy (n=44). Restrictive mitral annuloplasty vs. Baseline was evaluated on Postoperative adverse cardiac events (predicted by preoperative severe pulmonary hypertension, systolic PAP >60 mmHg) (HR 6.8, 95% CI 1.1-41.9, p=0.04). Restrictive mitral annuloplasty for functional mitral regurgitation resulted in sustained improvement of hemodynamics and left ventricular function, while preoperative severe pulmonary hypertension strongly predicted postoperative adverse cardiac events (HR 6.8).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: